betaine
betaine is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Cystadane. Available dosage form: powder, for solution.
Drug details
- Generic Name
- betaine
- Brand Names
- Cystadane
- Application Number
- NDA020576
- Sponsor
- Recordati Rare Diseases
- NDC Codes
- 1
- Dosage Forms
- POWDER, FOR SOLUTION
- Routes
- ORAL
- Active Ingredients
- BETAINE
Indications and Usage
1 INDICATIONS & USAGE Betaine Anhydrous for Oral Solution is indicated for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations in pediatric and adult patients. Included within the category of homocystinuria are Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency Cobalamin cofactor metabolism (cbl) defect Betaine Anhydrous for Oral Solution is a methylating agent indicated in pediatric and adult patients for the treatment of homocystinuria to decrease elevated homocysteine blood concentrations. Included within the category of homocystinuria are: Cystathionine beta-synthase (CBS) deficiency 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency Cobalamin cofactor metabolism (cbl) defect